Clinical Trial Update: Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update for desmopressin orally disintegrating tablets in Japanese female subjects with nocturia due to nocturnal polyuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia
• Nocturnal Polyuria

Drugs mentioned

• Desmopressin ODT (orally disintegrating tablets) (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 3 | Status: COMPLETED